The conclave aims to position Uttar Pradesh as a leading pharmaceutical and medical device manufacturing hub, supported by robust infrastructure, a vast consumer market, and forward-looking, investor-friendly policies.
Moreover, to bridge the gap until generic versions become available, Gilead has also committed to supply the product at no profit to the chosen companies until the selected generic manufacturers are able to fully support demand.
Dr Reddy's Laboratories, Inc, the US arm of Dr Reddy's Laboratories, is recalling 37,560 bottles of Tizanidine HCl tablets, USP 4 mg
Bourses in Shanghai, Tokyo and Seoul ended on a positive note, while Hong Kong was in the red.
Clegene has agreed to provide Dr. Reddy’s with a license to sell volume-limited amounts.
Drug firm Dr Reddy’s Laboratories on Monday said it has launched Cefixime for oral suspension, used for treatment of bacterial…
